Hacker News new | past | comments | ask | show | jobs | submit login

It could bypass patents, but instead it is owned by Merck, Giant Pharma so they can now bypass all the patents for themselves



Exactly! I’m sure the first customers of this software will be the big pharma patent departments who will use it to further expand their patent space.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: